. . . . . . . . . . . . . "p(HGNC:CD40) -> p(HGNC:TNFSF10)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Interestingly, agonist anti-CD40 mAb further enhanced the IFN-alpha-induced TRAIL/Apo-2L expression on CD19+ B cells." . . "Selventa" . . . . "2014-07-03T14:30:25.628+02:00"^^ . . .